List of Shire (pharmaceutical company) patents

Patent 7410799 was granted and assigned to Shire (pharmaceutical company) on August, 2008 by the United States Patent and Trademark Office.

Patent 9814764 was granted and assigned to Shire (pharmaceutical company) on November, 2017 by the United States Patent and Trademark Office.

Patent 9522176 was granted and assigned to Shire (pharmaceutical company) on December, 2016 by the United States Patent and Trademark Office.

Patent 7138262 was granted and assigned to Shire (pharmaceutical company) on November, 2006 by the United States Patent and Trademark Office.

Patent 11033459 was granted and assigned to Shire (pharmaceutical company) on June, 2021 by the United States Patent and Trademark Office.

Patent 9283181 was granted and assigned to Shire (pharmaceutical company) on March, 2016 by the United States Patent and Trademark Office.

Patent 9682129 was granted and assigned to Shire (pharmaceutical company) on June, 2017 by the United States Patent and Trademark Office.

Patent 9603908 was granted and assigned to Shire (pharmaceutical company) on March, 2017 by the United States Patent and Trademark Office.

Patent 9546128 was granted and assigned to Shire (pharmaceutical company) on January, 2017 by the United States Patent and Trademark Office.

Patent 7229793 was granted and assigned to Shire (pharmaceutical company) on June, 2007 by the United States Patent and Trademark Office.

Patent 9770410 was granted and assigned to Shire (pharmaceutical company) on September, 2017 by the United States Patent and Trademark Office.

Patent 8227212 was granted and assigned to Shire (pharmaceutical company) on July, 2012 by the United States Patent and Trademark Office.

Patent 10456454 was granted and assigned to Shire (pharmaceutical company) on October, 2019 by the United States Patent and Trademark Office.

Patent 9206235 was granted and assigned to Shire (pharmaceutical company) on December, 2015 by the United States Patent and Trademark Office.

Patent 11634468 was granted and assigned to Shire (pharmaceutical company) on April, 2023 by the United States Patent and Trademark Office.

Patent 9051556 was granted and assigned to Shire (pharmaceutical company) on June, 2015 by the United States Patent and Trademark Office.

Patent 9220677 was granted and assigned to Shire (pharmaceutical company) on December, 2015 by the United States Patent and Trademark Office.

Patent 7094400 was granted and assigned to Shire (pharmaceutical company) on August, 2006 by the United States Patent and Trademark Office.

Patent 9320711 was granted and assigned to Shire (pharmaceutical company) on April, 2016 by the United States Patent and Trademark Office.

Patent 11065308 was granted and assigned to Shire (pharmaceutical company) on July, 2021 by the United States Patent and Trademark Office.

Patent 9492511 was granted and assigned to Shire (pharmaceutical company) on November, 2016 by the United States Patent and Trademark Office.

Patent 9061021 was granted and assigned to Shire (pharmaceutical company) on June, 2015 by the United States Patent and Trademark Office.

Patent 9597413 was granted and assigned to Shire (pharmaceutical company) on March, 2017 by the United States Patent and Trademark Office.